Below are the most recent publications written about "Lung Diseases, Interstitial" by people in Profiles.
-
Ryerson CJ, Bankier A, Beasley MB, Brown K, Colby T, Cottin V, Desai S, Galvin J, Haramati LB, Hariri LP, Inoue Y, Johkoh T, Lee HY, Leung A, Lynch D, Muller N, Nicholson A, Raoof S, Revel MP, Remy-Jardin M, Richeldi L, Ryu JH, Schiebler M, Sholl L, Sverzellati N, Travis W, Walsh SLF, Wells AU, White CS, Johannson KA. Standardized Clinical Terms and Definitions for Interstitial Lung Disease: A Consensus Statement from the Fleischner Society. Am J Respir Crit Care Med. 2025 Oct; 211(10):1756-1774.
-
Alqalyoobi S, Smith JA, Maddali MV, Pugashetti JV, Newton CA, Kim JS, Linderholm AL, Chen CH, Ma SF, Bose S, Murray S, Adegunsoye A, Strek ME, Garcia CK, Wolters PJ, Martinez FJ, Noth I, Oldham JM. Proteomic Biomarkers of Survival in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease. Am J Respir Crit Care Med. 2025 Aug; 211(8):1452-1462.
-
Podolanczuk AJ, Hunninghake GM, Wilson KC, Khor YH, Kheir F, Pang B, Adegunsoye A, Cararie G, Corte TJ, Flanagan J, Gudmundsson G, Hariri LP, Hatabu H, Humphries SM, Kaul B, Kim JS, Konigshoff M, Kropski JA, Lee JS, Luo F, Lynch DA, Martinez FJ, Montesi SB, Moodley Y, Oldham JM, Piciucchi S, Putman RK, Richeldi L, Rosas IO, Salisbury ML, Salvatore MM, Selman M, Seo JB, Song JW, Thomson CC, Vivero M, Wain LV, Wijsenbeek M, Schwartz DA, Ryerson CJ. Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement. Am J Respir Crit Care Med. 2025 Jul; 211(7):1132-1155.
-
Kim BG, Lee H, Eun Y, Han K, Jung JH, Choi H, Kim H, Shin DW. Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study. Sci Rep. 2025 Feb 10; 15(1):4885.
-
Harder EM, Nardelli P, Pistenmaa CL, Ash SY, Balasubramanian A, Bowler RP, Iturrioz Campo M, Diaz AA, Hassoun PM, Leopold JA, Martinez FJ, Nathan SD, Noth I, Podolanczuk AJ, Saggar R, San Jos? Est?par R, Shlobin OA, Wang W, Waxman AB, Putman RK, Washko GR, Choi B, San Jos? Est?par R, Rahaghi FN. Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study. Am J Respir Crit Care Med. 2024 Nov 01; 210(9):1132-1142.
-
Baddour NA, Paulin LM, Gassett AJ, Woo H, Hoffman EA, Newell JD, Woodruff PG, Pirozzi CS, Barjaktarevic I, Barr RG, O'Neal W, Han MK, Martinez FJ, Peters SP, Hastie AT, Hansel NN, Ortega VE, Kaufman JD, Sack CS. Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2024 Sep; 21(9):1251-1260.
-
Huang Y, Ma SF, Oldham JM, Adegunsoye A, Zhu D, Murray S, Kim JS, Bonham C, Strickland E, Linderholm AL, Lee CT, Paul T, Mannem H, Maher TM, Molyneaux PL, Strek ME, Martinez FJ, Noth I. Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease. Am J Respir Crit Care Med. 2024 Aug 15; 210(4):444-454.
-
Kawano-Dourado L, Kulkarni T, Ryerson CJ, Rivera-Ortega P, Baldi BG, Chaudhuri N, Funke-Chambour M, Hoffmann-Vold AM, Johannson KA, Khor YH, Montesi SB, Piccari L, Prosch H, Molina-Molina M, Sellares Torres J, Bauer-Ventura I, Rajan S, Jacob J, Richards D, Spencer LG, Wendelberger B, Jensen T, Quintana M, Kreuter M, Gordon AC, Martinez FJ, Kaminski N, Cornelius V, Lewis R, Adams W, Jenkins G. Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases. Thorax. 2024 07 16; 79(8):788-795.
-
Choi B, Liu GY, Sheng Q, Amancherla K, Perry A, Huang X, San Jos? Est?par R, Ash SY, Guan W, Jacobs DR, Martinez FJ, Rosas IO, Bowler RP, Kropski JA, Banovich NE, Khan SS, San Jos? Est?par R, Shah R, Thyagarajan B, Kalhan R, Washko GR. Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study. Am J Respir Crit Care Med. 2024 05 01; 209(9):1091-1100.
-
Gao KM, Chiang K, Jiang Z, Korkmaz FT, Janardhan HP, Trivedi CM, Quinton LJ, Gingras S, Fitzgerald KA, Marshak-Rothstein A. Endothelial cell expression of a STING gain-of-function mutation initiates pulmonary lymphocytic infiltration. Cell Rep. 2024 04 23; 43(4):114114.